Leadership of the early clinical development strategy for novel therapy programs from Preclinical Candidate approval through Clinical Pharmacology testing (Phase 1), and clinical Proof-of-Concept (Phase 2)
Development of biomarker strategies through cross-functional teams that provide line-of-sight from First-in-Human studies through clinical Proof-of-Concept
Contributing to the identification of novel targets by partnering with discovery research teams
Development and execution of clinical pharmacology strategies to support later stages of development from Proof-of-Concept (Phase 2) through worldwide marketing application
Safe and timely execution of Phase I studies
Clear, timely communication and interpretation of study results to therapeutic area governance, functional area experts and development review committees
Requirements
MD or MD/PhD
Proven track record in clinical medicine or clinical research
Background in biomedical research
Demonstrated record of scientific scholarship and achievement including publications or presentations
Strong interpersonal, writing and presentation skills
Ability to function in a team environment
Clinical Board Certification or Eligibility preferred
Prior experience in translational research and/or early clinical development preferred but not required
Proven track record in clinical care of patient populations or management of clinical problem-solving
Benefits
medical, dental, vision healthcare and other insurance benefits (for employee and family)